Cohance Lifesciences Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 550.71 | 571.17 | 563.48 | 412.59 | 322.86 |
| Other Income Qtr Cr | 6.16 | 15.60 | 14.17 | 10.57 | 15.71 |
| Operating Revenues Qtr | 544.55 | 555.57 | 549.31 | 402.02 | 307.15 |
Loading chart... | |||||
Operating Expenses Qtr | 449.20 | 434.62 | 437.30 | 328.46 | 189.45 |
Operating Profit Qtr | 95.35 | 120.95 | 112.01 | 73.56 | 117.70 |
EBITDA Qtr Cr | 96.65 | 136.55 | 118.08 | 84.13 | 133.41 |
Depreciation Qtr | 46.94 | 44.02 | 45.14 | 26.78 | 20.35 |
Net Profit Qtr | 36.72 | 74.08 | 48.88 | 42.01 | 82.88 |
Basic EPS Qtr | 0.96 | 1.94 | 1.28 | 1.65 | 3.26 |
Open Demat Account